Clinical validation of the CD32b biomarker on the European market

Marina Y Konopleva

Targeting hypoxic microenvironment in Acute Lymphocytic Leukemia

Leukaemia

Xuefang Cao

Targeting Granzyme B to Separate GVH from GVL Responses

Non-Hodgkin lymphoma Leukaemia Hodgkin lymphoma

Monica J Justice

The Pluripotency Regulator Prdm14 Initiates Cancer by Epigenetic Mechanisms

Leukaemia

Hematology and hematologic malignancies Pathology

Katy Rezvani

Curative Cell-based Therapies for Chronic Lymphocytic Leukemia

Leukaemia

Hematology and hematologic malignancies

Gregory Armstrong

Childhood Cancer Survivor Study

Non-Hodgkin lymphoma Leukaemia Kidney, renal pelvis and ureter Hodgkin lymphoma Brain, nervous system

Pediatric oncology or childhood cancer

Catherine Ju-Ying Wu

The role of the SF3B1 splicing factor in chronic lymphocytic leukemia

Leukaemia

Andrew G Myers

Synthesis and Study of Natural and Non-natural Antiproliferative Agents

Multiple myeloma and immunoproliferative diseases Leukaemia

Hematology and hematologic malignancies Pathology

Ashley Marie Pandolfi

Unraveling crucial roles of homeobox gene Hlx in hematopoiesis and leukemogenesis

Leukaemia

Hematology and hematologic malignancies

Richard Aplenc

Genetic Predictors of AML Treatment Response

Leukaemia

Hematology and hematologic malignancies Pediatric oncology or childhood cancer